LifeScience Clinical & Diagnostic
Waters Introduces 1 mm I.D. Microflow LC Columns With MaxPeak Premier Technology
Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput...
February 19, 2026 | News
QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology To Expand Global Immunoassay Portfolio
Agreement adds new analyzer platforms and expands assay menu across key international markets QuidelOrtho has entered a long-term strategic supply agreeme...
February 18, 2026 | News
Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma
Beactica Therapeutics AB, a Swedish precision medicine company, announced that it, together with leading glioblastoma researchers at KU Leuven, has been aw...
February 18, 2026 | News
P Cure Reports First Prospective Clinical Evidence Supporting Gantry Less Upright Proton Therapy For Lung Cancer Re Irradiation
P-Cure, a supplier of compact, gantry-less proton therapy systems, announced the first-ever prospective clinical results demonstrating the feasibility, saf...
February 18, 2026 | News
Bio Techne Corporation Announces CE IVD Marking For Ella Benchtop Immunoassay Platform In European Union
Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform tha...
February 18, 2026 | News
CStone Pharmaceuticals Secures US FDA IND Clearance For Phase II Trial Of CS2009 In Advanced Solid Tumours
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA...
February 17, 2026 | News
Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong
Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...
February 16, 2026 | News
HanchorBio Secures FDA Orphan Drug Designation For HCB101 In Gastric Cancer
First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...
February 16, 2026 | News
Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...
February 16, 2026 | News
Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH
Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...
February 13, 2026 | News
ArkBio Receives FDA IND Clearance For AK3280 Phase Two Trial In Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) applicat...
February 13, 2026 | News
WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility
WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...
February 13, 2026 | News
Insilico Medicine And China Medical System Forge Multi Project AI Drug Discovery Alliance
Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Ho...
February 12, 2026 | News
Helix Partners With Mawi DNA To Broaden Access To Non Invasive Genomic Sample Collection
Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expa...
February 12, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
